Dithranol
SIGMA/D2773 - ≥90% (HPLC)
Synonym: 1,8,9-
CAS Number: 1143-38-0
Empirical Formula (Hill Notation): C14H10O3
Molecular Weight: 226.23
EC Number: 214-538-0
MDL Number: MFCD00053409
Linear Formula: C14H10O3
Product Type: Chemical
| assay | ≥90% (HPLC) |
| form | solid |
| InChI | 1S/C14H10O3/c15-10-5-1-3- |
| InChI key | NUZWLKWWNNJHPT-UHFFFAOYSA |
| mp | 178-181 °C (lit.) |
| Quality Level | 200 ![]() |
| SMILES string | Oc1cccc2Cc3cccc(O)c3C(=O) |
| solubility | chloroform: 20 mg/mL, clear to very slightly hazy, yellow |
| Application: | Dithranol, a potential anti-psoriasis medication, may be used to study its safety, efficacy, metabolism and pharmacological profile. Dithranol may be used to study is physicochemical properties, as a reference compound and to develop effective drug delivery vehicles. Dithranol may be used as a matrix for matrix assisted laser desorption/ionization imaging on a Fourier transform ion cyclotron resonance mass spectrometer. |
| General description: | Dithranol (1, 8 - dihydroxy-9-anthrone) is also called as anthralin. It is a vital topical antipsoriatic drugs. Dithranol, an athracene derivative, is a free radical generating mitochondrial poison that induces apoptosis in keratinocytes. |
| Other Notes: | To gain a comprehensive understanding of our extensive range of Polysaccharides for your research, we encourage you to visit our Carbohydrates Category page. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥90% (HPLC) |
| mp | 178-181 °C (lit.) |
| UNSPSC | 12352201 |


